Perspective Therapeutics (CATX) Notes Payables (2023 - 2026)
Perspective Therapeutics (CATX) posted Notes Payables of $56000.0 for Q1 2026, little changed sequentially from $56000.0 in Q4 2025, and up 5.66% YoY from $53000.0 in Q1 2025.
Perspective Therapeutics (CATX) Notes Payables (2023 - 2026) Analysis & Trends
Perspective Therapeutics has reported Notes Payables for 4 years, with the latest figure at $56000.0 in Q1 2026.
- Quarterly Notes Payables rose 5.66% year-over-year to $56000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56000.0 (up 5.66% YoY) and the FY2025 annual result came in at $56000.0, up 7.69% from the prior year.
- Notes Payables steadied at $56000.0 in Q1 2026 per CATX's latest filing, from $56000.0 in the prior quarter.
- Over five years, Notes Payables peaked at $80000.0 in Q1 2023 and troughed at $48000.0 in Q3 2023.
- A 4-year average of $56076.9 and a median of $54000.0 in 2024 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2024 and 2025: Notes Payables slumped 37.5% in 2024, then increased 7.84% in 2025.
- Over 4 years, Notes Payables stood at $49000.0 in 2023, then rose by 6.12% to $52000.0 in 2024, then rose by 7.69% to $56000.0 in 2025, then changed by 0.0% to $56000.0 in 2026.
- According to Business Quant data, Notes Payables over the past three periods registered $56000.0, $56000.0, and $55000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 388.50 Mn | 388.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57,000.00 |
| Mar 31, 2026 | 56,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Jun 30, 2023 | 71,000.00 |
| Mar 31, 2023 | 80,000.00 |